James Wheless, MD: Perampanel Shows Sustained Real-World Efficacy
December 18th 2019The professor and chief of pediatric neurology, and director of the comprehensive epilepsy program and neuroscience institute at Le Bonheur Children’s Hospital, detailed his experience with patients treated with perampanel.
Sumeet Vadera, MD: Advances in Epilepsy Surgery
December 17th 2019The director of epilepsy surgery and associate professor of neurosurgery at UC Irvine spoke to the advances that have been made in epilepsy surgery and in noninvasive or minimally invasive techniques, as well as the impact they’ve had on outcomes.
Joseph Sullivan, MD: The Benefits of Fenfluramine Treatment in Dravet Syndrome
December 12th 2019The professor of neurology and pediatrics and director of the Pediatric Epilepsy Center at the University of California, San Francisco, discussed his personal experience with fenfluramine and the advantages that the drug may present when treating patients with Dravet syndrome.
Elizabeth Thiele, MD, PhD: CBD Shows Low-Dose Efficacy and Safety in TSC
December 10th 2019The director of pediatric epilepsy and the Herscot Center for Tuberous Sclerosis Complex at Massachusetts General Hospital, and professor of neurology at Harvard Medical School spoke to the safety outcomes from GWPCARE6 and CBD’s low-dose efficacy.
Aimee W. Smith, PhD: Addressing Quality of Life In Epilepsy
December 9th 2019The assistant professor of psychology at East Carolina University offered insight about the resources are available to physicians and providers and what techniques can be useful to help patients have a better quality of life in light of refractory and uncontrolled seizures.
Sumeet Vadera, MD: The Consequences of Forgoing Epilepsy Surgery
December 9th 2019The director of epilepsy surgery and associate professor of neurosurgery at UC Irvine spoke about the consequences of patients choosing to forgo beneficial surgery and the importance of communication between surgeon and epileptologist.
Sumeet Vadera, MD: Barriers to Getting Patients to Epilepsy Surgery
December 8th 2019The director of epilepsy surgery and associate professor of neurosurgery at UC Irvine discussed the challenges he has encountered in getting patients with epilepsy to undergo beneficial procedures, often due to misinformation.
Elizabeth Thiele, MD, PhD: GWPCARE6 Trial of CBD in Tuberous Sclerosis Complex
December 8th 2019The director of pediatric epilepsy and the Herscot Center for Tuberous Sclerosis Complex at Massachusetts General Hospital, and professor of neurology at Harvard Medical School discussed the findings of the GWPCARE6 trial of cannabidiol.
James Wheless, MD: Treating Seizure Clusters With Midazolam
December 8th 2019The professor and chief of pediatric neurology, and director of the comprehensive epilepsy program and neuroscience institute at Le Bonheur Children’s Hospital offered insight into his experience with midazolam and its potential to play a vital role in treating seizure clusters.
Andre Machado, MD, PhD: Referrals for Deep Brain Stimulation
November 26th 2019The Chairman of the Neurological Institute at Cleveland Clinic discussed getting patient referrals for deep brain stimulation and how often patients miss the window during which the treatment could offer them benefit.
Edward Wild, MBBChir, PhD, MA: Generation HD1 Study of RG6042
November 19th 2019The neurologist at the Huntington’s Disease Center at University College London spoke about the clinical development of RG6042 in the treatment of Huntington disease, and what to expect from the GENERATION HD1 study.